Journal of Clinical Pharmacology
-
Publication Venue For
- A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS-986231 in Healthy Volunteers.. 59:717-730. 2019
- Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia.. 59:374-385. 2019
- Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.. 56:176-185. 2016
- Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis.. 55:39-44. 2015
- Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.. 54:917-927. 2014
- In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc.. 48:1179-1188. 2008
- Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.. 48:464-474. 2008
- Simultaneous measurement of in vivo P-glycoprotein and cytochrome P450 3A activities.. 46:1313-1319. 2006
- Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity.. 45:1187-1197. 2005
- Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination.. 45:79-88. 2005
- Quinidine as a probe for the role of p-glycoprotein in the intestinal absorption and clinical effects of fentanyl.. 44:224-233. 2004
- Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children.. 43:133-140. 2003
- Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.. 42:388-394. 2002
- Intraindividual variability in male hepatic CYP3A4 activity assessed by alfentanil and midazolam clearance.. 39:664-669. 1999
- Menstrual cycle variability in midazolam pharmacokinetics.. 39:275-280. 1999
- Oral ondansetron pharmacokinetics: the effect of chemotherapy.. 34:767-773. 1994
- The mechanism of action of steroid hormones: a new twist to an old tale.. 33:1165-1172. 1993
- A 19-YEAR-OLD MAN WITH ALTERED MENTAL STATUS. 32:511-519. 1992
- A nineteen-year-old man with altered mental status.. 32:511-519. 1992
- Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension.. 30:425-437. 1990
- Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension.. 29:33-40. 1989
- Falsely elevated urinary excretion of catecholamines and metanephrines in patients receiving labetalol therapy.. 27:288-292. 1987
- EFFECT OF PHENOBARBITAL (PB) ON PHENYTOIN (PHT) BIOTRANSFORMATION DETERMINED BY STABLE ISOTOPE TECHNIQUE. 26:544-544. 1986
- Combined effect of bumetanide and metolazone in normal volunteers.. 25:369-373. 1985
- Treatment of chronic orthopedic pain with zomepirac.. 20:385-391. 1980
- TREATMENT OF CHRONIC ORTHOPEDIC PAIN WITH ZOMEPIRAC. 20:385-391. 1980
- Treatment of chronic orthopedic pain with zomepirac. 20:385-391. 1980
- SIROLIMUS DOSE-NORMALIZED TROUGHS WERE AFFECTED BY TIME POST SIROLIMUS INITIATION, CONCOMITANT TACROLIMUS THERAPY, AND MDR-1 3435C > T POLYMORPHISM IN RENAL TRANSPLANT PATIENTS WHO ARE CYP3A5 NON-EXPRESSERS 2009